|
Class 2 Device Recall Siemens Dimension(R) Tacrolimus Flex(R) reagent cartridge (DF107) |
|
Date Initiated by Firm |
November 27, 2012 |
Date Posted |
March 15, 2013 |
Recall Status1 |
Terminated 3 on August 04, 2014 |
Recall Number |
Z-0957-2013 |
Recall Event ID |
63767 |
510(K)Number |
K060502
|
Product Classification |
Enzyme immunoassay, tacrolimus - Product Code MLM
|
Product |
Siemens Dimension(R) Tacrolimus Flex(R) reagent cartridge (DF107). The TACR method is used as an in vitro diagnostic test. |
Code Information |
Lot numbers FA3085, exp 2013-03-26; and FA3316, exp 2013-11-12 |
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc. 500 GBC Drive, Mailstop 514 PO BOX 6101 Newark DE 19714-6101
|
For Additional Information Contact |
302-631-6311
|
Manufacturer Reason for Recall |
Siemens has confirmed customer complaints of low patient sample recovery with Dimension(R) TACR Flex(R) lot FA3085.
Quality Control (QC) materials have not exhibited low recovery of the same magnitude.
Internal method regression testing versus LC/MS has shown an average 25% low bias compared to LC/MS across the assay range. Individual patients, particularly samples with lower TACR values
|
FDA Determined Cause 2 |
Process control |
Action |
The firm initiated their recall of this product on November 27, 2012 by sending a letter to all consignees. The letter included a recall effectiveness check form to be completed by the consignee and returned to the firm. The firm expanded their recall on January 29, 2013 by sending another letter to consignees. This letter also included a recall effectiveness check form to be completed by the consignee and returned to the firm. |
Quantity in Commerce |
2,976 |
Distribution |
Product was distributed within the United States to AL, AZ, CA, DC, FL, LA, MD, MI, MO, NJ, NM, NC, OH, OR, PA, TN, TX, UT, VA, and WA. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = MLM and Original Applicant = DADE BEHRING, INC.
|
|
|
|